← Open Payments lookup

ROBERT ZAPOTOSKY: Open Payments

NPI 1841648573 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$640 in 29 payments from 11 companies in 2025. Trend: 2023 $2,577 · 2024 $50 · 2025 $640

Food & beverage: $640
CompanyPaymentsAmount
ABBVIE INC.9$145
Novartis Pharmaceuticals Corporation4$103
Arcutis Biotherapeutics, Inc.4$102
GENZYME CORPORATION2$86
Incyte Corporation3$60
Lilly USA, LLC1$33
Janssen Biotech, Inc.2$33
Amgen Inc.1$27
UCB, Inc.1$21
LNHC, Inc1$16

Products named: Zoryve, DUPIXENT, SKYRIZI, Rhapsido, RINVOQ, OPZELURA, TALTZ, TREMFYA.

Industry payments across CA — which companies pay providers there.